| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,802 |
5,815 |
$2.01M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,173 |
7,294 |
$1.28M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,185 |
7,979 |
$305K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17,511 |
8,199 |
$246K |
| 71046 |
Radiologic examination, chest; 2 views |
1,298 |
1,104 |
$137K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
465 |
432 |
$132K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
205 |
176 |
$123K |
| G0378 |
Hospital observation service, per hour |
141 |
110 |
$95K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
375 |
200 |
$79K |
| 87430 |
|
5,381 |
4,917 |
$74K |
| 71045 |
Radiologic examination, chest; single view |
1,031 |
896 |
$71K |
| 80050 |
General health panel |
1,436 |
1,308 |
$58K |
| J3490 |
Unclassified drugs |
3,405 |
1,285 |
$57K |
| 73630 |
|
501 |
437 |
$55K |
| 80053 |
Comprehensive metabolic panel |
7,047 |
5,864 |
$53K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,668 |
6,513 |
$45K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
637 |
560 |
$42K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
10,880 |
4,390 |
$37K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
174 |
146 |
$33K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
121 |
114 |
$31K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,229 |
1,999 |
$30K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
62 |
58 |
$25K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
191 |
159 |
$23K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
956 |
888 |
$19K |
| A0425 |
Ground mileage, per statute mile |
127 |
108 |
$18K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
3,082 |
2,754 |
$17K |
| 87420 |
|
1,311 |
1,168 |
$16K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,857 |
1,436 |
$14K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
96 |
88 |
$11K |
| 85027 |
|
2,111 |
1,783 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
244 |
191 |
$9K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
48 |
26 |
$9K |
| 80061 |
Lipid panel |
799 |
721 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
303 |
285 |
$7K |
| 84436 |
|
1,196 |
1,091 |
$6K |
| 82670 |
|
257 |
239 |
$6K |
| 84479 |
|
1,198 |
1,092 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
79 |
26 |
$6K |
| 81001 |
|
2,604 |
2,279 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
336 |
297 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
711 |
650 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
94 |
25 |
$5K |
| 93307 |
|
32 |
29 |
$5K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
39 |
39 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
363 |
322 |
$4K |
| 83001 |
|
253 |
235 |
$4K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
66 |
39 |
$4K |
| 84403 |
|
147 |
139 |
$3K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
13 |
13 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
62 |
58 |
$2K |
| 87486 |
|
62 |
58 |
$2K |
| 87581 |
|
62 |
58 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,031 |
816 |
$2K |
| 94664 |
|
180 |
26 |
$2K |
| 83880 |
|
70 |
57 |
$2K |
| 82172 |
|
89 |
71 |
$1K |
| 99220 |
|
12 |
12 |
$1K |
| 74018 |
|
15 |
12 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
326 |
248 |
$1K |
| 84484 |
|
164 |
129 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
30 |
13 |
$1K |
| 86003 |
|
26 |
14 |
$970.83 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
334 |
271 |
$956.86 |
| 83010 |
|
88 |
83 |
$952.15 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
129 |
116 |
$885.11 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
80 |
36 |
$877.37 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
269 |
25 |
$840.37 |
| 90686 |
|
32 |
32 |
$800.40 |
| 99222 |
Initial hospital care, per day, moderate complexity |
26 |
13 |
$734.03 |
| 0002A |
|
24 |
23 |
$730.80 |
| 82150 |
|
160 |
138 |
$717.36 |
| 11721 |
|
52 |
50 |
$700.14 |
| 82553 |
|
116 |
93 |
$679.27 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
31 |
13 |
$547.00 |
| 86140 |
|
146 |
118 |
$489.49 |
| 82977 |
|
77 |
72 |
$471.46 |
| 11056 |
|
19 |
18 |
$450.09 |
| J2704 |
Injection, propofol, 10 mg |
693 |
505 |
$444.75 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
13 |
13 |
$433.94 |
| 86308 |
|
89 |
86 |
$422.08 |
| 87070 |
|
61 |
29 |
$417.85 |
| 0001A |
|
33 |
26 |
$413.92 |
| 83883 |
|
75 |
70 |
$406.87 |
| 81025 |
|
56 |
52 |
$386.18 |
| 84550 |
|
119 |
101 |
$385.16 |
| 84478 |
|
74 |
69 |
$352.90 |
| 85651 |
|
110 |
97 |
$325.46 |
| 82465 |
|
74 |
69 |
$263.09 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$260.72 |
| 82550 |
|
76 |
57 |
$247.20 |
| 87040 |
|
29 |
27 |
$246.75 |
| 86800 |
|
17 |
15 |
$240.17 |
| 86376 |
|
17 |
15 |
$219.64 |
| 84439 |
|
23 |
23 |
$207.46 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20 |
15 |
$196.92 |
| 84460 |
|
42 |
40 |
$183.15 |
| 84450 |
|
42 |
40 |
$178.99 |
| 87088 |
|
32 |
29 |
$178.96 |
| 82607 |
|
13 |
12 |
$167.57 |
| 82247 |
|
42 |
40 |
$158.72 |
| 91300 |
|
56 |
29 |
$148.32 |
| 82947 |
|
42 |
40 |
$135.81 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
40 |
30 |
$109.40 |
| 83550 |
|
15 |
12 |
$89.92 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
21 |
14 |
$77.17 |
| 82043 |
|
14 |
12 |
$63.58 |
| 88160 |
|
92 |
68 |
$45.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
233 |
138 |
$29.15 |
| 99000 |
|
380 |
333 |
$8.64 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
264 |
241 |
$0.00 |
| 85060 |
|
188 |
130 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
265 |
222 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
80 |
64 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
18 |
16 |
$0.00 |